Immuno-Oncology Technology

Open accessIn DOAJFee waivers availableMedicine

Cost to publish

$3,340

Open-access article processing charge, list price.

Time to publication

29 wks

Slower than average; plan your timeline accordingly.

h-index

22

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

0.4

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Immuno-Oncology Technology is listed at $3,340. The publisher also lists 3,050 EUR, 2,670 GBP, 414,260 JPY. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Immuno-Oncology Technology, as recorded by OpenAlex for each year. The fee has risen 21% since 2019, from $2,750 to $3,340.

$0$1.7k$3.3k2019: $2,75020192020: $3,09020202021: $3,19020212022: $3,19020222023: $3,02020232024: $3,17020242025: $3,3402025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY-NC-ND
Author keeps copyrightYes
Plagiarism screeningNot reported
Editorial boardPublished →
LanguagesEN

Verification checks

7 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.Confirmed
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.Confirmed
  • Peer review model publicly declaredAnonymous peer reviewConfirmed
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.Confirmed
  • Screens submissions for plagiarismReported to DOAJ by the journal.Not confirmed
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.Confirmed
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.Confirmed
  • Still actively publishingMost recent indexed article: 2026.Confirmed

Scope

The subjects Immuno-Oncology Technology publishes most, derived from the topics assigned to its indexed articles.

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy researchLung Cancer Treatments and MutationsLung Cancer Research StudiesCancer Genomics and DiagnosticsDiverse Scientific and Economic StudiesColorectal Cancer Treatments and StudiesCancer Research and TreatmentsMonoclonal and Polyclonal Antibodies Research

Publication record

Indexed articles1,238
Total citations2,052
i10-index51
Most recent indexed article2026
Open access since2019
All ISSNs2590-0188

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.